SEC Filing Details
Nov 19, 2020
Nov 18, 2020
Report of unscheduled material events or corporate event
KemPharm® is a clinical stage, specialty pharmaceutical company engaged in the development and discovery of proprietary prodrugs that are designed to be improved versions of widely prescribed and FDA approved products.